financetom
Business
financetom
/
Business
/
US SEC says JPMorgan Chase settles five enforcement cases, to pay $151 million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US SEC says JPMorgan Chase settles five enforcement cases, to pay $151 million
Oct 31, 2024 3:21 PM

NEW YORK, Oct 31 (Reuters) - JPMorgan Chase ( JPM ) will

pay $151 million to settle five U.S. Securities and Exchange

Commission enforcement cases, including accusations that the

largest U.S. bank made misleading disclosures to brokerage

customers, the regulator said on Thursday.

The settlements include $61 million of civil fines and

$90 million of reimbursements to customers. JPMorgan ( JPM ) did not

admit or deny wrongdoing in agreeing to the settlements.

"JPMorgan's ( JPM ) conduct across multiple business lines violated

various laws designed to protect investors from the risks of

self-dealing and conflicts of interest," Sanjay Wadhwa, acting

director of the SEC enforcement division, said in a statement.

In the largest settlement, JPMorgan ( JPM ) will pay a $10

million civil fine and reimburse $90 million to customers who

invested in "conduit" products.

These products pooled customer money to invest in private

equity or hedge funds that would later distribute shares of

companies that went public.

The SEC said JPMorgan ( JPM ) did not disclose that it had complete

discretion over when to sell shares and how many to distribute.

It said this exposed customers to market risk, including when

prices fell because the bank took months to sell the shares.

JPMorgan ( JPM ) was separately fined $45 million for failing to

fully disclose from July 2017 to October 2024 how the bank and

its brokers could benefit financially by recommending some

in-house investments over similar products managed by third

parties.

In a statement, the New York-based bank said it was

pleased to settle, strived to uphold high standards when serving

clients, and fixes problems when they arise.

The SEC also accused JPMorgan ( JPM ) of recommending some mutual

funds to 10,500 retail brokerage customers when materially less

expensive but otherwise identical exchange-traded fund (ETF)

products were available.

JPMorgan ( JPM ) voluntarily repaid those customers $15.2 million,

and was not fined after reporting the issue, the SEC said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Standard Lithium Up As JV Achieves Key Milestone at South West Arkansas Project
Standard Lithium Up As JV Achieves Key Milestone at South West Arkansas Project
Mar 11, 2025
10:50 AM EDT, 03/11/2025 (MT Newswires) -- Standard Lithium ( SLI ) said Tuesday that its Smackover Lithium joint venture with Equinor achieved one of the last technical milestones in the development of the South West Arkansas project in Arkansas. According to Standard Lithium ( SLI ), the joint venture and partner Koch Technology Solutions completed the final Direct Lithium...
What's Going On With Blink Charging Stock On Tuesday?
What's Going On With Blink Charging Stock On Tuesday?
Mar 11, 2025
Blink Charging Co. ( BLNK ) shares saw an uptick in Tuesday’s trading following the announcement of a significant contract win in the U.K. The company has been named the preferred bidder, subject to contract execution, by Brighton & Hove City Council for a 15-year agreement worth over £500,000 (~$646,370). This contract will involve the installation of a minimum of...
Sagimet Reports Acne Drug Candidate Cleared for Clinical Trials
Sagimet Reports Acne Drug Candidate Cleared for Clinical Trials
Mar 11, 2025
10:45 AM EDT, 03/11/2025 (MT Newswires) -- Sagimet Biosciences ( SGMT ) said Tuesday the US Food and Drug Administration's Division of Dermatology and Dentistry has cleared its investigational new drug application for TVB-3567. The company said the clearance allows it to enter clinical development for the treatment of acne, with a first-in-human phase 1 trial planned in 2025. TVB-3567...
High-Trend's Co-Founder Zhang Buying Roughly $4.5 Million Ordinary Shares
High-Trend's Co-Founder Zhang Buying Roughly $4.5 Million Ordinary Shares
Mar 11, 2025
10:50 AM EDT, 03/11/2025 (MT Newswires) -- High-Trend International Group ( HTCO ) said Tuesday its co-founder Dong Zhang has signed a securities purchase deal to buy roughly 1.7 million of the company's class A ordinary shares for about $4.5 million, or $2.62 apiece. The proceeds will be used for general working capital purposes, the shipping company said, adding that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved